D’Ambrosio, A.; Altomare, A.; Boscarino, T.; Gori, M.; Balestrieri, P.; Putignani, L.; Del Chierico, F.; Carotti, S.; Cicala, M.; Guarino, M.P.L.;
et al. Mathematical Modeling of Vedolizumab Treatment’s Effect on Microbiota and Intestinal Permeability in Inflammatory Bowel Disease Patients. Bioengineering 2024, 11, 710.
https://doi.org/10.3390/bioengineering11070710
AMA Style
D’Ambrosio A, Altomare A, Boscarino T, Gori M, Balestrieri P, Putignani L, Del Chierico F, Carotti S, Cicala M, Guarino MPL,
et al. Mathematical Modeling of Vedolizumab Treatment’s Effect on Microbiota and Intestinal Permeability in Inflammatory Bowel Disease Patients. Bioengineering. 2024; 11(7):710.
https://doi.org/10.3390/bioengineering11070710
Chicago/Turabian Style
D’Ambrosio, Antonio, Annamaria Altomare, Tamara Boscarino, Manuele Gori, Paola Balestrieri, Lorenza Putignani, Federica Del Chierico, Simone Carotti, Michele Cicala, Michele Pier Luca Guarino,
and et al. 2024. "Mathematical Modeling of Vedolizumab Treatment’s Effect on Microbiota and Intestinal Permeability in Inflammatory Bowel Disease Patients" Bioengineering 11, no. 7: 710.
https://doi.org/10.3390/bioengineering11070710
APA Style
D’Ambrosio, A., Altomare, A., Boscarino, T., Gori, M., Balestrieri, P., Putignani, L., Del Chierico, F., Carotti, S., Cicala, M., Guarino, M. P. L., & Piemonte, V.
(2024). Mathematical Modeling of Vedolizumab Treatment’s Effect on Microbiota and Intestinal Permeability in Inflammatory Bowel Disease Patients. Bioengineering, 11(7), 710.
https://doi.org/10.3390/bioengineering11070710
